Alimera Sciences Competitors and Similar CompaniesClear all
Alimera Sciences's competitors and similar companies include Biogen and Chiesi Group.
 Alimera Sciences Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | |
Founding Date | Founding Date 2003 | Founding Date 1978 | Founding Date 1935 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Alpharetta, US HQ Berlin, DE Dublin 2, IE Lisboa, PT Hampshire, GB | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees 1222% decrease | Employees 7,605 | Employees 5,8541% increase |
Valuation ($) | Valuation ($) 301.3 m | Valuation ($) 26.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $80.8m (FY, 2023) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) €2.4b (Y, 2021) |
Gross profit | Gross profit $69.9m (FY, 2023) | Gross profit $7.5b (FY, 2025) | Gross profit N/A |
Net income | Net income ($20.1m) (FY, 2023) | Net income $1.3b (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View company